title: Localization of the oncogene c-Ha-ras1 outside the aniridia-Wilms' tumor-associated deletion of chromosome 11(del 11p13) using somatic cell hybrids.
abstract: Hybrid cell lines, obtained after fusion of rodent cells with leukocytes from a patient with the aniridia-Wilms' tumor syndrome and carrying a specific constitutional deletion in chromosome #11 (del.11p13), were assayed for the presence of the c-Ha-ras1 oncogene. This sequence has recently been assigned to the p-arm of chromosome #11 and, hence, has been suggested to be involved in the development of renal tumors in patients with this syndrome. Positive hybridization of a cellular Ha-ras1 probe to hybrid cell DNA was observed, irrespective of whether the normal chromosome #11 or its deleted homologue was present. The results presented here suggest that c-Ha-ras1 is located outside the region 11p12-11p14, bounded by the chromosomal breakpoints observed in the patient used. Therefore, we conclude that predisposition of aniridia patients to develop Wilms' tumors is not due to a constitutional deletion of one of the c-Ha-ras1 alleles.
authors.forename: A G
authors.initials: AG
authors.lastname: van Kessel
authors.forename: R
authors.initials: R
authors.lastname: Nusse
authors.forename: R
authors.initials: R
authors.lastname: Slater
authors.forename: P
authors.initials: P
authors.lastname: Tetteroo
authors.forename: A
authors.initials: A
authors.lastname: Hagemeijer
mesh_terms: D002872:Chromosome Deletion; D002906:Chromosomes, Human, 6-12 and X; D000013:Congenital Abnormalities / Q000235:genetics; D006801:Humans; D007498:Iris / Q000002:abnormalities*; D008297:Male; D009857:Oncogenes; D013577:Syndrome; D009396:Wilms Tumor / Q000235:genetics*